首页 >
法规速递
-
Document: Guideline on good pharmacovigilance practices (GVP): Product- or population-specific considerations III: Pregnant and breastfeeding women and their children exposed in utero or via breastmilk - with tracked changes-2026/2/6
2026-02-09查看详情 > -
Document: Comments received from public consultation on good pharmacovigilance practices (GVP) Product- or Population-Specific Considerations III: Pregnant and breastfeeding women (EMA/653036/2019)-2026/2/6
2026-02-09查看详情 > -
Document: Guidelines on good pharmacovigilance practices (GVP): Introductory cover note, last updated with final considerations on pregnant and breastfeeding women and their children exposed in utero or via breastmilk-2026/2/6
2026-02-09查看详情 > -
Document: Guideline on good pharmacovigilance practices (GVP): Product- or population-specific considerations III: Pregnant and breastfeeding women and their children exposed in utero or via breastmilk-2026/2/6
2026-02-09查看详情 > -
Page: Good pharmacovigilance practices (GVP)-2026/2/6
2026-02-09查看详情 > -
Page: Archive of development of good pharmacovigilance practices-2026/2/6
2026-02-09查看详情 > -
Page: Fees for veterinary medicines-2026/2/6
2026-02-09查看详情 > -
Page: Fees for human medicines-2026/2/6
2026-02-09查看详情 > -
Document: Highlights – 1st European Medicine Agency (EMA) and European Respiratory Society (ERS) bilateral meeting-2026/2/6
2026-02-09查看详情 > -
Page: Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices-2026/2/6
2026-02-09查看详情 >
